HODGKIN LYMPHOMA. A COMPREHENSIVE OVERVIEW

- Evaluates new treatment options for both first-line and relapsed disease
- Offers clear guidance on management of special patient groups and Hodgkin survivors
- Discusses pathogenesis, clinical evaluation, imaging diagnosis, staging systems, and prognostic factors
This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocytepredominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.

Table of contents (26 chapters)
1.Epidemiology
2.The Role of Viruses in the Genesis of Hodgkin Lymphoma
3.Pathology and Molecular Pathology of Hodgkin Lymphoma
4.Microenvironment, Crosstalk, and Immune Escape Mechanisms
5.What Will We Learn from Genomics and Proteomics in Hodgkin Lymphoma?
6.Clinical Evaluation
7.Functional Imaging in Hodgkin Lymphoma
8.Prognostic Factors
9.Principles of Radiation Therapy for Hodgkin Lymphoma
10.Principles of Chemotherapy in Hodgkin Lymphoma
11.Treatment of Early Favorable Hodgkin Lymphoma
12.Treatment of Early Unfavorable HL
13.Treatment of Advanced-Stage Hodgkin Lymphoma
14.Pediatric Hodgkin Lymphoma
15.The Management of Older Patients with Hodgkin Lymphoma
16.Nodular Lymphocyte-Predominant Hodgkin Lymphoma
17.The Management of Hodgkin Lymphoma During Pregnancy
18.The Management of HIV-Hodgkin Lymphoma
19.Relapsed and Refractory Hodgkin Lymphoma
20.Allogeneic Transplantation for Relapsed Hodgkin Lymphoma
21.Targeting CD30 in Patients with Hodgkin Lymphoma
22.Other New Agents for Hodgkin Lymphoma
23.Quality of Life in Hodgkin Lymphoma
24.Second Malignancy Risk After Treatment of Hodgkin Lymphoma
25.Cardiovascular and Pulmonary Late Effects
26.Gonadal Dysfunction and Fertility Preservation in Hodgkin Lymphoma Patients